维普中文期刊产品整合服务
19篇 您的检索式:作者名="Liberty D"
    题名 作者 年代 出处 被引量
1Development of an immunoassay-based lateral flow dipstick for the rapid detection of aflatoxin B1 in pig feed显示文摘BARBARA S D SARAH M D G S LIBERTY S 2005Agric Food Chem2005,53,:1
2Platelet count,MPV and their relation to prognosis in cerebral infarction显示文摘D′Erasmo E A liberti G Celi F S 1990J Intern Med1990,227,:1
3Bi-directional routing of DNA mismatch repair protein human exonuclease 1 to replication loci and DNA double strand breaks显示文摘Liberti S E Andersen S D Wang J 2011DNA Repair (Amst)2011,10,1:1
4Lateral-flow colloidal gold-based immtmoassay for the rapid detection of deoxynivalenol with two indicator ranges显示文摘Anna Y K Liberty S Frederic D 2008Analytica Chimica Acta2008,616,:1
5Boceprevir or telaprevir in hepatitis C virus chronic infection:The Italian real life experience显示文摘AIM: To check the safety and efficacy of boceprevir/telaprevir with peginterferon/ribavirin for hepatitis C virus(HCV) genotype 1 in the real-world settings. METHODS: This study was a non-randomized, observational, prospective, multicenter. This study involved 47 centers in Italy. A database was prepared for the homogenous collection of the data, was used by all of the centers for data collection, and was updated continuously. All of the patients enrolled in this study were older than 18 years of age and were diagnosed with chronic infection due to HCV genotype 1. The HCV RNA testing was performed using COBAS-Taq Man2.0(Roche, LLQ 25 IU/m L). RESULTS: All consecutively treated patients were included. Forty-seven centers enrolled 834 patients as follows: Male 64%; median age 57(range 18-78), of whom 18.3% were over 65; mean body mass index 25.6(range 16-39); genotype 1b(79.4%); diagnosis of cirrhosis(38.2%); and fibrosis F3/4(71.2%). The following drugs were used: Telaprevir(66.2%) and PEG-IFN-alpha2a(67.6%). Patients were na?ve(24.4%), relapsers(30.5%), partial responders(14.8%) and null responders(30.3%). Overall, adverse events(AEs) occurred in 617 patients(73.9%) during the treatment. Anemia was the most frequent AE(52.9% of cases), especially in cirrhotic. The therapy was stopped for 14.6% of the patients because of adverse events or virological failure(15%). Sustained virological response was achieved in 62.7% of the cases, but was 43.8% in cirrhotic patients over 65 years of age. CONCLUSION: In everyday practice, triple therapy is safe but has moderate efficacy, especially for patients over 65 years of age, with advanced fibrosis, nonresponders to peginterferon + ribavirin.Antonio Ascione Luigi Elio Adinolfi Pietro Amoroso Angelo Andriulli Orlando Armignacco Tiziana Ascione Sergio Babudieri Giorgio Barbarini Michele Brogna Francesco Cesario Vincenzo Citro Ernesto Claar Raffaele Cozzolongo Giuseppe D’Adamo Emilio D’Amico Pellegrino Dattolo Massimo De Luca Vincenzo De Maria Massimo De Siena Giuseppe De Vita Antonio Di Giacomo Rosanna De Marco Giorgio De Stefano Giulio De Stefano Sebastiano Di Salvo Raffaele Di Sarno Nunzia Farella Laura Felicioni Basilio Fimiani Luca Fontanella Giuseppe Foti Caterina Furlan Francesca Giancotti Giancarlo Giolitto Tiziana Gravina Barbara Guerrera Roberto Gulminetti Angelo Iacobellis Michele Imparato Angelo Iodice Vincenzo Iovinella Antonio Izzi Alfonso Liberti Pietro Leo Gennaro Lettieri Ileana Luppino Aldo Marrone Ettore Mazzoni Vincenzo Messina Roberto Monarca Vincenzo Narciso Lorenzo Nosotti Adriano Maria Pellicelli Alessandro Perrella Guido Piai Antonio Picardi Paola Pierri Grazia Pietromatera Francesco Resta Luca Rinaldi Mario Romano Angelo Rossini Maurizio Russello Grazia Russo Rodolfo Sacco Vincenzo Sangiovanni Antonio Schiano Antonio Sciambra Gaetano Scifo Filomena Simeone Annarita Sullo Pierluigi Tarquini Paolo Tundo Alfredo Vallone 2016World Journal of Hepatology2016,8,22:1
6Disinfection byproducts formation during wastewater disinfection with peracetic acid显示文摘DelFerba A Falsanisi D Liberti L 2007Desalination2007,215,1:1
7A field study of DRAM errors显示文摘Sridharan V Liberty D 2012Studies2012,3,5:1
8A rapid resazur- in-based microtiter assay to evaluate QoI sensitivity for Alternaria alternata isolates and their molecular characterization 显示文摘Vega B Liberti D Harmon P F et ai 2012Plant Disease2012,96,:1
9Partial genome sequence of an apricot isolate of Cherry green ring mottle virus(CGRMV)显示文摘Liberti D Marais A Svanella-Dumas L 2005Archives of Virology2005,150,1:1
10REM NUT ion exchange plus struvite precipitation process显示文摘Liberti L Petruzzelli D Florio L De 2001Environmental Technology2001,22,11:1
11Development of a collodial- gold - based lateral - flow immunoassay for the rapid simultaneous de - tection of zearalenone and deoxynivaleno 显示文摘Anna Y K Sarah D S Liberty S 2007Anal Bioanal Chem2007,389,78:1
12A phosphate-selective sorbent for the Rem Nut process: field experience at Massafra Wastewater Treatment Plant显示文摘Petruzzelli D Dell'Erba A Liberti L 2004Reactive & Functional Polymers2004,60,:1
13Surgery for intracerebral hemorrhage 显示文摘Collice M D~liberti G Talamonti G 2004NeurolSci2004,25,1:1
14REM NUT Ion Exchange PlusStruvite Precipitation Process 显示文摘Liberti L Petruzzelli D De Florio L 2001Environmental Technology2001,22,11:1
15Chloride/sulfate exchange kinetics: solution for combined film and particle diffusion control 显示文摘PETRUZZELLI D LIBERTI L PASSINO R HELFFERICH G HWANG Y L 1987React Polym1987,5,:1
16Atypical antipsychotics and dibetes mellitus:an association显示文摘Liberty IF Todder D Umansky R 2004Israel Medical Association Journal2004,6,:1
17Cell cycle phase perturbations and apoptosis in tumor cells induced by aplidine 显示文摘Erba E Bassano L Liberti G D 2002Br J Cancer2002,86,9:1
18REM NUT ion exchange plus struvite precipitation process 显示文摘Liberti L Petruzzelli D De Florio L 2001Environmental Technology2001,22,11:1
19Improved REM-NUT for P-recovery显示文摘Liberti L Petruzzelli L Florio L D 2004Scope Newsletter2004,55,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费